1. Home
  2. CRMT vs CTXR Comparison

CRMT vs CTXR Comparison

Compare CRMT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$2.13

Market Cap

19.7M

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.55

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
CTXR
Founded
1981
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
18.9M
IPO Year
2026
2010

Fundamental Metrics

Financial Performance
Metric
CRMT
CTXR
Price
$2.13
$0.55
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$29.50
$6.00
AVG Volume (30 Days)
946.4K
426.4K
Earning Date
06-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
43.38
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.92
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.48
52 Week High
$62.55
$2.24

Technical Indicators

Market Signals
Indicator
CRMT
CTXR
Relative Strength Index (RSI) 21.83 41.90
Support Level $1.38 $0.48
Resistance Level $13.68 $0.74
Average True Range (ATR) 1.49 0.04
MACD -0.43 -0.00
Stochastic Oscillator 6.98 16.67

Price Performance

Historical Comparison
CRMT
CTXR

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: